Search
Filter Results
Displaying 21–30 of 578 for “Retinitis pigmentosa”
-
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Year 2024 (July 1, 2024 – June 30, 2025)
-
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Year 2020 (July 1, 2019-June 30, 2020)
-
Apr 7, 2026
Recording Available: Insights Forum | Thursday, March 26, 2026
Foundation NewsThe Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the blinding diseases community. The call took place on March 26, 2026.
-
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Year 2021 (July 1, 2020–June 30, 2021)
-
Funded Foundation Fighting Blindness Grants and Awards for Fiscal Year 2024 (July 1, 2023 – June 30, 2024)
-
VISIONS 2024, the national conference of the Foundation Fighting Blindness, is a one-of-a-kind event in which individuals who are visually impaired, and their families, have the opportunity to hear about exciting advancements in blindness research.
-
Aug 16, 2019
Foundation Fighting Blindness Investing Nearly $6.5 Million in New Grants
Foundation NewsThe newly funded research efforts include several therapies that have strong potential to treat a wide range of inherited retinal diseases.
-
Aug 3, 2026
Summary of the 11th Annual Retinal Therapeutics Innovation Summit
Research NewsThe 11th annual Retinal Therapeutics Innovation Summit featured 25 presentations from industry professionals worldwide and more than 400 attendees.
-
Sep 27, 2021
Foundation Awarded 21 New Grants in FY2021 Totaling More than $14.2 Million
Research NewsCurrent research portfolio is comprised of nearly 100 projects at prominent institutions around the world
-
Jun 17, 2026
A Race Against Blindness Commits $1 Million to Advance Gene-Agnostic Therapeutic Approaches
Foundation NewsThe commitment directs $775,000 to the RD Fund, to be matched dollar for dollar, and $225,000 to a Foundation Fighting Blindness research award, advancing approaches that can help patients regardless of the gene causing their retinal disease